(PubMed) Ziegler D, Nowak H, Kempler P, Vargha P, Low PA
Common clinical goals for BPC-157 include: Supporting soft-tissue healing (tendons, ligaments, muscles, and fascia) after injury or overuse Promoting post-surgical recovery and tissue regeneration Reducing inflammation and associated pain in joints and musculoskeletal conditions Supporting gut lining integrity and symptoms related to gastric ulcers, IBS, or leaky gut Assisting recovery from sports-related injuries and enhancing exercise recovery Supporting blood flow to injured tissues to aid repair Adjunctive support for chronic pain related to tissue or nerve injury Addressing Common Misconceptions and Questions Surrounding BPC-157 Online discussions often include myths that can cloud understanding
On the contrary, it acts as a compulsory exchanger, mediating the influx of leucine into the cell and the efflux of glutamine out of the cell [29, 42]
A study in aged mice published in Nature Scientific Reports showed that NNMT inhibition promoted stem cell activation following injury
Nature Communications (2025) 9